Ironwood pharmaceuticals revenue
WebFeb 17, 2024 · Ironwood Pharmaceuticals Inc. reported fourth quarter revenue and adjusted earnings above analyst expectations. Fourth quarter total revenue came to $116.7 million, … WebApr 12, 2024 · Shares of IRWD opened at $10.77 on Wednesday. Ironwood Pharmaceuticals, Inc. has a 1 year low of $9.73 and a 1 year high of $12.66. The company has a market cap of $1.66 billion, a price-to ...
Ironwood pharmaceuticals revenue
Did you know?
WebFunding, Valuation & Revenue 9 Fundings Ironwood Pharmaceuticals's latest funding round was a IPO for $188M on February 12, 2010. Ironwood Pharmaceuticals's latest post-money valuation is from February 2010. Sign up for a free trial to see Ironwood Pharmaceuticals's valuations in February 2010 and more. View all funding WebApr 15, 2024 · Analysts have estimated the company’s revenue for the quarter at $100.05 million, with a low estimate of $99.3 million and a high estimate of $101 million. ...
WebIronwood Pharmaceuticals is a Pharmaceutical Manufacturing, Drug Manufacturing & Research, and Biotechnology company located in Cambridge, Massachusetts with … WebApr 14, 2024 · The business had revenue of $107.20 million during the quarter, compared to analyst estimates of $108.23 million. Ironwood Pharmaceuticals had a net margin of 42.64% and a return on equity of 30.49%. The business's revenue for the quarter was down 8.5% on a year-over-year basis. During the same period last year, the company earned $0.27 EPS.
WebFeb 17, 2024 · Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Results; LINZESS® (linaclotide) Achieves Blockbuster Status as U.S. Net Sales Exceed $1 Billion in 2024 – 2024 total revenue of $414 million, driven primarily by $400 million in … WebIronwood Pharmaceuticals, headquartered in Boston, Massachusetts, and established in 1998, is a specialty and generic drug manufacturing company specializing in …
WebApr 15, 2024 · The company had revenue of $107.20 million for the quarter, compared to analyst estimates of $108.23 million. Ironwood Pharmaceuticals had a net margin of 42.64% and a return on equity of 30.49%. Ironwood Pharmaceuticals’s revenue for the quarter was down 8.5% on a year-over-year basis. During the same quarter last year, the firm posted …
WebIronwood Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Results February 13, 2024 Ironwood Pharmaceuticals Announces FDA Filing Acceptance and Priority Review of … fmvf70ydw ssdWebIronwood Pharma Ironwood Revenue $422.4 M Employees 219 Primary Industries Pharmaceuticals Manufacturing Funding History Ironwood Pharmaceuticals raised a total of $1.4 B in funding over 11 rounds, and is a public traded company. CEO Thomas McCourt Stock Symbol NASDAQ: IRWD Ironwood Pharmaceuticals Executive Team & Key Decision … greensleeves piano sheet music amebWebFeb 16, 2024 · Ironwood , which belongs to the Zacks Medical - Drugs industry, posted revenues of $107.2 million for the quarter ended December 2024, missing the Zacks Consensus Estimate by 3.13%. This compares... greensleeves piano slow and easyWebIronwood Pharmaceuticals, Inc. is an entrepreneurial pharmaceutical company. ... Total Enterprise Value to Total Revenue (ttm) 3.33. Markets data provided by S&P and by Xignite. fmvf70ydw 説明書WebIronwood Pharmaceuticals is a leading gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI patients. One in five Americans suffer from GI diseases, resulting in millions of hospital visits and tens of billions in healthcare costs each year. greensleeves piano sheet music freeWebApr 10, 2024 · See how Ironwood Pharmaceuticals compares to its main competitors: Hoffmann-LA Roche Inc has the most employees (101,200). Employees at AstraZeneca earn more than most of the competitors, with an average yearly salary of $112,988. fmvf70ydw ssd交換WebFind company research, competitor information, contact details & financial data for Ironwood Pharmaceuticals, Inc. of Boston, MA. Get the latest business insights from Dun & Bradstreet. D&B Business Directory ... 2024 Revenue: $413.75. 2024 Revenue: $413.75. Actual. Gross Profit: $413.75; Operating Income: $232.22; Income Before Tax: $200.66; greensleeves reggae classics